EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EYPT EyePoint

休市中 08-21 16:00:00 EDT

5.32

-0.08

-1.48%

盘后5.30

-0.02-0.38%

19:57 EDT

最高5.50	最低4.98	成交量818.64万
今开5.48	昨收5.40	日振幅9.72%
总市值4.59亿	流通市值3.41亿	总股本8,621万
成交额4,251万	换手率12.78%	流通股本6,406万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":5.32,"timestamp":1787342400000,"preClose":5.4,"halted":0,"volume":8186380,"hourTrading":{"tag":"盘后","latestPrice":5.3,"preClose":5.32,"latestTime":"19:57 EDT","volume":39793,"amount":209865.4281,"timestamp":1787356640004,"change":-0.02,"changeRate":-0.003759,"amplitude":0.026316},"delay":0,"changeRate":-0.014814814814814828,"floatShares":64057000,"shares":86212138,"eps":-3.764176,"marketStatus":"休市中","change":-0.08,"latestTime":"08-21 16:00:00 EDT","open":5.475,"high":5.5,"low":4.975,"amount":42508261.14642,"amplitude":0.097222,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.764176,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.4,"preHourTrading":{"tag":"盘前","latestPrice":5.4989,"preClose":5.4,"latestTime":"09:26 EDT","volume":35709,"amount":195686.5483896,"timestamp":1787318819911,"change":0.0989,"changeRate":0.018315,"amplitude":0.04037},"postHourTrading":{"tag":"盘后","latestPrice":5.3,"preClose":5.32,"latestTime":"19:57 EDT","volume":39793,"amount":209865.4281,"timestamp":1787356640004,"change":-0.02,"changeRate":-0.003759,"amplitude":0.026316},"volumeRatio":0.4693131112545878,"optionData":{"bulkOrders":[{"symbol":"EYPT","call":true,"expireDate":1797570000000,"strike":"12.5","timestamp":1787334457759,"price":0.8,"volume":10000,"amount":800000,"type":"-"},{"symbol":"EYPT","call":true,"expireDate":1797570000000,"strike":"2.5","timestamp":1787334457759,"price":3.5,"volume":10000,"amount":3500000,"type":"+"}]},"impliedVol":1.2606,"impliedVolPercentile":0.6853},"requestUrl":"/m/hq/s/EYPT/tweets","defaultTab":"tweets","newsList":[{"id":"2660465855","title":"眼科管线失利刷屏，贝达药业20CM跌停，公司回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465855","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660465855?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:17","pubTimestamp":1787044631,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LU0320765992.SGD","EYPT","BK4585","BK4007","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660556264","title":"贝达药业20CM跌停，EyePoint美股隔夜大跌67%，伏罗尼布wAMD三期临床失败，贝达药业拥有大中华区权益。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660556264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660556264?lang=zh_cn&edition=full","pubTime":"2026-08-18 09:39","pubTimestamp":1787017169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4588","EYPT","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174905289","title":"EyePoint公布Lugano试验顶线数据——湿性AMD候选药物Duravyu™ 2.7Mg两项关键III期临床研究首项结果揭晓","url":"https://stock-news.laohu8.com/highlight/detail?id=1174905289","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174905289?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:01","pubTimestamp":1786964507,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals今日宣布，其备受关注的关键性III期临床试验Lugano研究的顶线数据已正式出炉。这项研究是评估Duravyu 2.7Mg在湿性年龄相关性黄斑变性治疗中疗效与安全性的两项 pivotal 试验中的第一项，其结果的公布标志着该公司在眼科治疗领域迈出了至关重要的一步。随着Lugano研究的尘埃落定，行业目光现已转向第二项关键性III期试验的最终结果，该数据的问世将进一步明确Duravyu 2.7Mg在湿性AMD治疗格局中的潜在定位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","EYPT","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110675913","title":"EyePoint宣布Duravyu™两类关键性III期临床试验完成受试者入组，旨在治疗糖尿病性黄斑水肿（DME）","url":"https://stock-news.laohu8.com/highlight/detail?id=1110675913","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110675913?lang=zh_cn&edition=full","pubTime":"2026-07-30 19:09","pubTimestamp":1785409767,"startTime":"0","endTime":"0","summary":"EyePoint已完成其旨在治疗糖尿病性黄斑水肿（DME）的Duravyu™药物的两项关键性III期临床试验的受试者入组。这一里程碑标志着该药物研发进入新的阶段。Duravyu™作为一种潜在的新疗法，正致力于为DME患者提供更有效的治疗选择。此次入组完成，将推动后续数据读取及分析工作的开展，为评估该药的疗效与安全性奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4585","EYPT","LU0320765992.SGD","BK4588","BK4007","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112077828","title":"EyePoint宣布Duravyu™湿性年龄相关性黄斑变性三期试验获独立数据监查委员会第三次积极建议，为2026年中顶线数据增添信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1112077828","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112077828?lang=zh_cn&edition=full","pubTime":"2026-05-14 19:01","pubTimestamp":1778756486,"startTime":"0","endTime":"0","summary":"EyePoint近日宣布，其针对湿性年龄相关性黄斑变性的候选药物Duravyu进行的关键三期临床试验，再次获得了独立数据监查委员会的积极建议。这是该委员会连续第三次对试验的进展与安全性给予正面评价。此次积极的监管反馈，进一步增强了市场对Duravyu临床开发计划的信心。这一里程碑式的进展，凸显了EyePoint在眼科治疗领域的研发实力与Duravyu的潜在价值。随着试验按计划推进，投资者对2026年的数据发布抱有更高期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0109394709.USD","LU0889565916.HKD","BK4007","BK4588","EYPT","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143779601","title":"EyePoint公司遭起诉：指控涉及诽谤、商业诋毁及侵权干扰","url":"https://stock-news.laohu8.com/highlight/detail?id=1143779601","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143779601?lang=zh_cn&edition=full","pubTime":"2026-03-21 04:40","pubTimestamp":1774039203,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，EyePoint公司面临一项法律诉讼。该起诉书中明确提出多项指控，包括诽谤、商业诋毁以及侵权干扰等主张。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","BK4585","EYPT","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195908932","title":"诉讼指控Ocular Therapeutix就EyePoint及Duravyu发布虚假声明——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1195908932","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195908932?lang=zh_cn&edition=full","pubTime":"2026-03-21 04:36","pubTimestamp":1774039019,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件，一项诉讼指控生物技术公司Ocular Therapeutix针对EyePoint公司及其产品Duravyu散布了不实信息。该法律文件指出，Ocular Therapeutix通过公开声明传播了有关EyePoint业务及Duravyu产品的虚假内容。目前案件细节仍在进一步披露中，此事可能对两家公司的市场声誉及投资者关系产生重要影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4585","EYPT","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165654593","title":"EyePoint公司于2026年3月20日向马萨诸塞州米德尔塞克斯县高等法院对Ocular Therapeutix提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=1165654593","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165654593?lang=zh_cn&edition=full","pubTime":"2026-03-21 04:36","pubTimestamp":1774039017,"startTime":"0","endTime":"0","summary":"2026年3月20日，EyePoint公司已正式向美国马萨诸塞州米德尔塞克斯县高等法院递交诉状，对生物技术公司Ocular Therapeutix提起诉讼。此举标志着两家在眼科治疗领域具有重要影响力的企业之间法律纠纷的公开化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4585","EYPT","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106945439","title":"EyePoint宣布Duravyu™治疗糖尿病黄斑水肿的两项全球三期临床试验首批患者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1106945439","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106945439?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:02","pubTimestamp":1772452939,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals宣布，其创新药物Duravyu™针对糖尿病黄斑水肿治疗的两项全球三期临床试验已成功完成首批患者给药。这一重要进展标志着该疗法向商业化迈出关键一步，为全球数百万糖尿病患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","BK4585","LU0320765992.SGD","BK4007","BK4588","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518289200","title":"Eyepoint Pharmaceuticals, Inc.2024财年实现净利润-1.31亿美元，同比减少85.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518289200?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536045,"startTime":"0","endTime":"0","summary":"3月10日，Eyepoint Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.31亿美元，同比减少85.03%；其中营业收入为43.27百万美元，同比减少5.98%，每股基本收益为-2.32美元。从资产负债表来看，Eyepoint Pharmaceuticals, Inc.总负债81.96百万美元，其中短期债务1.25百万美元，资产负债比为0.06，流动比率为0.08。机构评级：截至2025年3月10日，当前有12家机构对Eyepoint Pharmaceuticals, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为18.00美元，最高目标价为68.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000101a26897f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000101a26897f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517215166","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517215166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517215166?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271457,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.02%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Plus Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为904.80%、95.93%、44.61%，振幅较大的相关个股有Mbx Biosciences, Inc.、Tiziana Life Sciences Ltd、Neuphoria Therapeutics Inc.，振幅分别为8.18%、8.09%、5.97%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223057abeb7730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223057abeb7730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4585","BK4007","LU0889565916.HKD","BK4588","LU0320765992.SGD","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517488839","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.09%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517488839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517488839?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:40","pubTimestamp":1741185615,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时40分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.09%。截至发稿，该股报6.45美元/股，成交量2.5492万股，换手率0.04%，振幅4.49%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为408.84%、265.02%、198.88%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Exicure, Inc.，振幅分别为23.90%、20.71%、18.00%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224015a260ca86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224015a260ca86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","BK4585","BK4588","LU0889565916.HKD","BK4007","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516659415","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 快速下跌5.10%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516659415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516659415?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:27","pubTimestamp":1741022862,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时27分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.10%。截至发稿，该股报5.95美元/股，成交量28.3541万股，换手率0.42%，振幅9.73%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Bioxcel Therapeutics, Inc.、Alto Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4191.65%、177.48%、156.72%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012743abe668bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012743abe668bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","EYPT","LU0889565916.HKD","BK4585","BK4588","LU0320765992.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514338749","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.08%报6.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514338749?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:33","pubTimestamp":1740674008,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时33分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.08%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Alpha Tau Medical Ltd C/Wts 、Heron Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1668.94%、270.98%、113.20%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Quoin Pharmaceuticals Ltd、Pds Biotechnology Corporation，振幅分别为86.14%、47.79%、45.45%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003328abdf8be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003328abdf8be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4585","EYPT","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512655411","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 大幅上涨5.08%报6.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512655411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512655411?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889128,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.08%。截至发稿，该股报6.83美元/股，成交量1.8195万股，换手率0.03%，振幅2.15%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为276.09%、91.01%、60.62%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、8.35%、6.13%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223208a24aacba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223208a24aacba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","BK4585","EYPT","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511869691","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511869691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511869691?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544539,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.23%。截至发稿，该股报6.64美元/股，成交量3.3712万股，换手率0.05%，振幅4.28%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1852.91%、485.12%、421.78%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485998858e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485998858e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0889565916.HKD","LU0320765992.SGD","EYPT","BK4585","BK4007","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510864388","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510864388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510864388?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:52","pubTimestamp":1739202744,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时52分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.00%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2670.33%、1536.97%、1006.83%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为87.80%、69.83%、66.09%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023522498808885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023522498808885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4585","EYPT","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509282518","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌13.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509282518?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:30","pubTimestamp":1738765804,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时30分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅下跌13.12%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Oragenics Inc.、Nanoviricides, Inc.、Cognition Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为1970.72%、561.06%、552.84%，振幅较大的相关个股有Kairos Pharma, Ltd.、Can Fite Biopharma Ltd、Actinium Pharmaceuticals, Inc. ，振幅分别为5.75%、4.32%、2.56%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223005a23a79db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223005a23a79db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4588","BK4585","LU0320765992.SGD","BK4007","EYPT","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509546126","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 临近午盘快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509546126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509546126?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:49","pubTimestamp":1738687763,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时49分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.16%。截至发稿，该股报7.54美元/股，成交量11.9164万股，换手率0.17%，振幅5.02%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1678.40%、935.96%、549.21%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为72.82%、49.88%、47.32%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050049239617ede7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050049239617ede7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4588","BK4585","LU0320765992.SGD","BK4007","EYPT","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507702586","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.17%报8.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507702586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507702586?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:23","pubTimestamp":1738268607,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时23分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.17%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Dominari Holdings Inc.涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1824.88%、333.27%、255.30%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Kazia Therapeutics Limited，振幅分别为70.55%、65.98%、65.94%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104232796146408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013104232796146408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","EYPT","BK4007","LU0889565916.HKD","BK4585","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eyepointpharma.com","stockEarnings":[{"period":"1week","weight":-0.6393},{"period":"1month","weight":-0.5798},{"period":"3month","weight":-0.5886},{"period":"6month","weight":-0.653},{"period":"1year","weight":-0.5414},{"period":"ytd","weight":-0.7088}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"EyePoint, Inc.于2008年3月19日在特拉华州注册成立，是一家临床阶段的生物制药公司，致力于开发和商业化创新疗法，以帮助改善患有严重视网膜疾病的患者的生活。公司采用其专有的生物可降解Durasert E技术进行持续的眼内药物输送，从而解决了频繁玻璃体内注射带来的难题。其主要候选产品DURAVYU是一种用于治疗血管内皮生长因子介导的视网膜疾病的在研疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.047593},{"month":2,"riseRate":0.409091,"avgChangeRate":0.004657},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.012715},{"month":4,"riseRate":0.545455,"avgChangeRate":0.149596},{"month":5,"riseRate":0.409091,"avgChangeRate":0.002025},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.017015},{"month":7,"riseRate":0.590909,"avgChangeRate":0.036041},{"month":8,"riseRate":0.318182,"avgChangeRate":-0.049297},{"month":9,"riseRate":0.380952,"avgChangeRate":0.007468},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.047614},{"month":11,"riseRate":0.47619,"avgChangeRate":-0.049639},{"month":12,"riseRate":0.380952,"avgChangeRate":0.116746}],"exchange":"NASDAQ","name":"EyePoint","nameEN":"EyePoint"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"EyePoint,EYPT,EyePoint股票,EyePoint股票老虎,EyePoint股票老虎国际,EyePoint行情,EyePoint股票行情,EyePoint股价,EyePoint股市,EyePoint股票价格,EyePoint股票交易,EyePoint股票购买,EyePoint股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}